Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New drug price controversy looms as Biogen stuns payers with Spinraza’s $750K sticker — analyst
New drug price controversy looms as Biogen stuns payers with Spinraza’s $750K sticker — analyst
New drug price controversy looms as Biogen stuns payers with Spinraza’s $750K sticker — analyst
Submitted by
admin
on December 29, 2016 - 12:24pm
Source:
Endpoints
News Tags:
Biogen
Spinraza
drug pricing
spinal muscular atrophy
Headline:
New drug price controversy looms as Biogen stuns payers with Spinraza’s $750K sticker — analyst
Do Not Allow Advertisers to Use My Personal information
